F,N-doped carbon dot as an efficient Type I photosensitizer for photodynamic therapy

2022 ◽  
Author(s):  
Xiaoyan Wu ◽  
Mingsheng Xu ◽  
Shuna Wang ◽  
Khurram Abbas ◽  
Xin Huang ◽  
...  

Photodynamic therapy (PDT) is a promising and emerging method for the treatment of cancer, usually Type II PDT is used in the clinic, which is mainly consists of three key...

2012 ◽  
Vol 44 (6) ◽  
pp. 490-499 ◽  
Author(s):  
Liyi Huang ◽  
Yi Xuan ◽  
Yuichiro Koide ◽  
Timur Zhiyentayev ◽  
Masamitsu Tanaka ◽  
...  

2019 ◽  
Vol 2 (9) ◽  
pp. 3854-3860 ◽  
Author(s):  
Xiao Cui ◽  
Jinfeng Zhang ◽  
Yingpeng Wan ◽  
Fang Fang ◽  
Rui Chen ◽  
...  

Small ◽  
2020 ◽  
Vol 16 (23) ◽  
pp. 2001059 ◽  
Author(s):  
Dapeng Chen ◽  
Qing Yu ◽  
Xuan Huang ◽  
Hanming Dai ◽  
Tao Luo ◽  
...  

2010 ◽  
Vol 8 (2) ◽  
pp. 279-291 ◽  
Author(s):  
Venny Santosa ◽  
Leenawaty Limantara

Photodynamic therapy (PDT) is a considerably new kind of photochemotherapeutic treatment in medical field. It combines the use of three components, which are a photosensitizer, light and oxygen. Photosensitizer is a compound activated by light. The application can be oral, topical or intravenous. It usually member of porphyrin group with ampiphilic characteristics. Photosensitizer can be of generation I, II or III, each generation step develops more specificity, selectivity and deeper tissue application. This review will discuss photosensitizer development consecutively, with its benefit and lackness. The light used is usually on red region, while the oxygen is involved in reactive oxygen species generation. Its mechanism action can go through either in type I or type II reaction. This kind of therapy is usually being used in oncology, especially in superficial and in-lining cancers, dermatology and ophthalmology field. This therapy can be safely given to patients with complication and has distinct advantages compare with other treatment such as chemotherapy and surgery. It also considerably has lesser side effects and risks. Broader application is being developed through various experiments and photosensitizer modification.   Keywords: light spectrum, photoactivation, photodynamic therapy, photosensitizer


2020 ◽  
Vol 142 (16) ◽  
pp. 7334-7339 ◽  
Author(s):  
Taokun Luo ◽  
Kaiyuan Ni ◽  
August Culbert ◽  
Guangxu Lan ◽  
Zhe Li ◽  
...  

2009 ◽  
Vol 13 (01) ◽  
pp. 99-106 ◽  
Author(s):  
Noemí Rubio ◽  
Víctor Martínez-Junza ◽  
Jordi Estruga ◽  
José I. Borrell ◽  
Margarita Mora ◽  
...  

Biosubstrate-sensitizer binding is one of the factors that enhances the type-I mechanism over the type-II in the whole photodynamic process. 2,7,12,17-Tetraphenylporphycene (TPPo), a second-generation photosensitizer, is a hydrophobic compound with good photophysical properties for photodynamic therapy applications that has proved its ability for the photoinactivation of different cell lines. Nevertheless, little is known about its mechanism of action. This paper focuses on the study of the interaction/binding of TPPo with different model biomolecules that may favor the type-I mechanism in the overall photodynamic process, including nucleosides, proteins, and phospholipids. Compared with more hydrophilic photosensitizers, it is concluded that TPPo is more likely to undergo type-II (singlet oxygen) than type-I (electron transfer) photodynamic processes in biological environments.


Biomaterials ◽  
2021 ◽  
pp. 121255
Author(s):  
Yuewen Yu ◽  
Shuang Wu ◽  
Le Zhang ◽  
Shidang Xu ◽  
Chunhui Dai ◽  
...  

2021 ◽  
Author(s):  
Fu Wang ◽  
Zhi Su ◽  
Yanan Tian ◽  
Yuxin Huang ◽  
Xiaoyu Huang

Photodynamic therapy has received widespread attention in antitumor application. However, the tumor hypoxia microenvironment seriously suppresses the treatment efficience, especially for these oxygen-dependent type-II systems. Herein, novel nitrogen-doped carbon nanoparticles...


Sign in / Sign up

Export Citation Format

Share Document